Nanoparticles Loaded with the BET Inhibitor JQ1 Block the Growth of Triple Negative Breast Cancer Cells In Vitro and In Vivo

Inhibition of bromo-and extra-terminal domain (BET) proteins, epigenetic regulators of genes involved in cell viability, has been efficiently tested in preclinical models of triple negative breast cancer (TNBC). However, the use of the selective BET-inhibitor JQ1 on humans is limited by its very sho...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancers (Basel)
Egile Nagusiak: Maggisano, Valentina, Celano, Marilena, Malivindi, Rocco, Barone, Ines, Cosco, Donato, Mio, Catia, Mignogna, Chiara, Panza, Salvatore, Damante, Giuseppe, Fresta, Massimo, Andò, Sebastiano, Russo, Diego, Catalano, Stefania, Bulotta, Stefania
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: MDPI 2019
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7016573/
https://ncbi.nlm.nih.gov/pubmed/31905936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12010091
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak